Pandia Health is a doctor-founded, women-led telehealth company that prescribes and delivers birth control, acne treatment, and menopause hormone therapy across the United States. Founded in 2016 by Stanford-affiliated physician Dr. Sophia Yen and a team of clinicians and operators, the company built its business on a simple bet: most American women still struggle to get continuous access to hormonal medication, and a recurring, mail-order subscription paired with a board-certified physician network can fix it.
Concerto Biosciences is a Cambridge, Massachusetts microbiome company that turns microbial ecology into health products. Its patented kChip platform screens millions of microbial interactions in nanoliter droplets to discover 'ensembles' - small, defined groups of microbes that work together to shepherd a damaged microbial community back to health. The company's lead program, ENS-002, is a topical live biotherapeutic for atopic dermatitis that suppresses Staphylococcus aureus without nuking the skin's helpful microbes. Founded in 2020 by scientists out of MIT and the Broad Institute, Concerto pairs ultra-high-throughput biology with AI to make microbial communities predictable and engineerable.
Bobn L is the Chief Executive Officer of GoodRx, the Santa Monica-based digital health company that has become America's most-used prescription savings platform. GoodRx tracks drug prices across 75,000+ pharmacies nationwide, delivering coupons and transparency to millions of Americans navigating the opaque world of prescription pricing. Under executive leadership, GoodRx has grown to nearly $800 million in annual revenue, gone public on Nasdaq (GDRX), and expanded into telemedicine - all in service of a single idea: that patients deserve to know what their medications actually cost.
Zack Scott is a General Partner and Co-Head of the Healthcare Investment Team at Norwest Venture Partners, one of Silicon Valley's most active multi-stage venture capital firms. A rare combination of clinically trained physician and seasoned investor, Scott brings an MD from UT Health San Antonio and an MBA from Duke's Fuqua School of Business to a career that spans surgical residency, healthcare venture investing at Burrill & Company, co-founding Revelation Partners (a healthcare-focused secondary investment firm), and now leading healthcare deals at Norwest. His portfolio includes companies like ShiraTronics, SetPoint Medical, Cytovale, and Galvanize Therapeutics, with notable exits including Omada Health's IPO and acquisitions by Stryker, Zoll Medical, Abbott, and Olympus.